Title: Transplacental transfer of vancomycin and telavancin.
Journal: American journal of obstetrics and gynecology 20121001
Title: Compatibility and stability of telavancin and vancomycin in heparin or sodium citrate lock solutions.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20120815
Title: Successful treatment of methicillin-resistant Staphylococcus epidermidis prosthetic joint infection with telavancin.
Journal: The Journal of antimicrobial chemotherapy 20120801
Title: Rates of killing of methicillin-resistant Staphylococcus aureus by ceftaroline, daptomycin, and telavancin compared to that of vancomycin.
Journal: Scandinavian journal of infectious diseases 20120801
Title: Telavancin for the treatment of hospital-acquired pneumonia: findings from the ATTAIN studies.
Journal: Expert review of anti-infective therapy 20120801
Title: Activity of telavancin compared to other agents against coagulase-negative staphylococci with different resistotypes by time kill.
Journal: Diagnostic microbiology and infectious disease 20120701
Title: Efficacy of telavancin in patients with specific types of complicated skin and skin structure infections.
Journal: The Journal of antimicrobial chemotherapy 20120601
Title: Successful treatment of polymicrobial calcaneal osteomyelitis with telavancin, rifampin, and meropenem.
Journal: The Annals of pharmacotherapy 20120601
Title: Acute renal insufficiency during telavancin therapy in clinical practice.
Journal: The Journal of antimicrobial chemotherapy 20120301
Title: Detection of vancomycin levels in patients receiving telavancin but not vancomycin.
Journal: The Journal of antimicrobial chemotherapy 20120201
Title: Evaluation of telavancin activity versus daptomycin and vancomycin against daptomycin-nonsusceptible Staphylococcus aureus in an in vitro pharmacokinetic/pharmacodynamic model.
Journal: Antimicrobial agents and chemotherapy 20120201
Title: Management of gram-positive bacterial infections in patients with cancer.
Journal: Leukemia & lymphoma 20120101
Title: Telavancin activity tested against a contemporary collection of Gram-positive pathogens from USA Hospitals (2007-2009).
Journal: Diagnostic microbiology and infectious disease 20120101
Title: Efficacy and safety of telavancin in clinical trials: a systematic review and meta-analysis.
Journal: PloS one 20120101
Title: Telavancin for the treatment of serious gram-positive infections, including hospital acquired pneumonia.
Journal: Expert opinion on pharmacotherapy 20111201
Title: Physical compatibility of telavancin hydrochloride with select i.v. drugs during simulated Y-site administration.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20111201
Title: MRSA new treatments on the horizon: current status.
Journal: Injury 20111201
Title: Telavancin for the treatment of methicillin-resistant Staphylococcus aureus osteomyelitis.
Journal: The Journal of antimicrobial chemotherapy 20111101
Title: Successful treatment of methicillin-resistant Staphylococcus aureus mitral valve endocarditis with sequential linezolid and telavancin monotherapy following daptomycin failure.
Journal: The Journal of antimicrobial chemotherapy 20110901
Title: Update on the telavancin activity tested against European staphylococcal clinical isolates (2009-2010).
Journal: Diagnostic microbiology and infectious disease 20110901
Title: Comparative in vitro activity of telavancin, vancomycin and linezolid against heterogeneously vancomycin-intermediate Staphylococcus aureus (hVISA).
Journal: International journal of antimicrobial agents 20110601
Title: On a different level: telavancin versus vancomycin for hospital-acquired pneumonia.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20110601
Title: Susceptibility patterns of coagulase-negative staphylococci to several newer antimicrobial agents in comparison with vancomycin and oxacillin.
Journal: International journal of antimicrobial agents 20110301
Title: In vitro activity of telavancin and comparator antimicrobial agents against a panel of genetically defined staphylococci.
Journal: Diagnostic microbiology and infectious disease 20110301
Title: In vitro activity of dalbavancin and telavancin against staphylococci and streptococci isolated from patients in Canadian hospitals: results of the CANWARD 2007-2009 study.
Journal: Diagnostic microbiology and infectious disease 20110301
Title: Pharmacodynamics of telavancin studied in an in vitro pharmacokinetic model of infection.
Journal: Antimicrobial agents and chemotherapy 20110201
Title: Flow cytometry as a tool to determine the effects of cell wall-active antibiotics on vancomycin-susceptible and -resistant Enterococcus faecalis strains.
Journal: Antimicrobial agents and chemotherapy 20110101
Title: Telavancin versus vancomycin for hospital-acquired pneumonia due to gram-positive pathogens.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20110101
Title: Comparative efficacies of human simulated exposures of telavancin and vancomycin against methicillin-resistant Staphylococcus aureus with a range of vancomycin MICs in a murine pneumonia model.
Journal: Antimicrobial agents and chemotherapy 20101201
Title: Successful treatment of vancomycin-intermediate Staphylococcus aureus pacemaker lead infective endocarditis with telavancin.
Journal: Antimicrobial agents and chemotherapy 20101201
Title: ATLAS trials: efficacy and safety of telavancin compared with vancomycin for the treatment of skin infections.
Journal: Future microbiology 20101201
Title: Telavancin: a lipoglycopeptide antimicrobial for the treatment of complicated skin and skin structure infections caused by gram-positive bacteria in adults.
Journal: Clinical therapeutics 20101201
Title: Prevalence of antimicrobial-resistant pathogens in Canadian hospitals: results of the Canadian Ward Surveillance Study (CANWARD 2008).
Journal: Antimicrobial agents and chemotherapy 20101101
Title: Telavancin activity against Gram-positive bacteria isolated from respiratory tract specimens of patients with nosocomial pneumonia.
Journal: The Journal of antimicrobial chemotherapy 20101101
Title: Activity of telavancin and comparator antimicrobial agents tested against Staphylococcus spp. isolated from hospitalised patients in Europe (2007-2008).
Journal: International journal of antimicrobial agents 20101001
Title: In vitro activity of telavancin against Gram-positive isolates from complicated skin and skin structure infections: results from 2 phase 3 (ATLAS) clinical studies.
Journal: Diagnostic microbiology and infectious disease 20101001
Title: Telavancin Activity against gram-positive bacteria isolated from patients with skin and skin-structure infections.
Journal: Journal of chemotherapy (Florence, Italy) 20101001
Title: Direct fluorescence polarization assay for the detection of glycopeptide antibiotics.
Journal: Analytical chemistry 20100815
Title: Outpatient parenteral antimicrobial therapy: Recent developments and future prospects.
Journal: Current opinion in investigational drugs (London, England : 2000) 20100801
Title: Bactericidal activity of telavancin, vancomycin and metronidazole against Clostridium difficile.
Journal: Anaerobe 20100601
Title: Successful treatment of methicillin-resistant Staphylococcus aureus endocarditis with telavancin.
Journal: The Journal of antimicrobial chemotherapy 20100601
Title: In vitro activity of telavancin against a contemporary worldwide collection of Staphylococcus aureus isolates.
Journal: Antimicrobial agents and chemotherapy 20100601
Title: New lipoglycopeptides: a comparative review of dalbavancin, oritavancin and telavancin.
Journal: Drugs 20100507
Title: Antistaphylococcal activities of telavancin tested alone and in combination by time-kill assay.
Journal: Antimicrobial agents and chemotherapy 20100501
Title: Activity of telavancin against heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) in vitro and in an in vivo mouse model of bacteraemia.
Journal: The Journal of antimicrobial chemotherapy 20100401
Title: [Update on antimicrobial chemotherapy].
Journal: Medecine et maladies infectieuses 20100301
Title: Effect of Telavancin on the pharmacokinetics of the cytochrome P450 3A probe substrate midazolam: a randomized, double-blind, crossover study in healthy subjects.
Journal: Pharmacotherapy 20100201
Title: A comparative review of the lipoglycopeptides: oritavancin, dalbavancin, and telavancin.
Journal: Pharmacotherapy 20100101
Title: Comparative activity of telavancin and other antimicrobial agents against methicillin-resistant Staphylococcus aureus isolates collected from 1991 to 2006.
Journal: Chemotherapy 20100101
Title: Telavancin: a novel lipoglycopeptide.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20091215
Title: Presence of genes encoding the panton-valentine leukocidin exotoxin is not the primary determinant of outcome in patients with complicated skin and skin structure infections due to methicillin-resistant Staphylococcus aureus: results of a multinational trial.
Journal: Journal of clinical microbiology 20091201
Title: Antibiotics for gram-positive bacterial infections: vancomycin, teicoplanin, quinupristin/dalfopristin, oxazolidinones, daptomycin, dalbavancin, and telavancin.
Journal: Infectious disease clinics of North America 20091201
Title: New antimicrobial agents for methicillin-resistant Staphylococcus aureus.
Journal: Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine 20091201
Title: Activity of telavancin against staphylococci and enterococci determined by MIC and resistance selection studies.
Journal: Antimicrobial agents and chemotherapy 20091001
Title: Telavancin and hydroxy propyl-beta-cyclodextrin clearance during continuous renal replacement therapy: an in vitro study.
Journal: The International journal of artificial organs 20091001
Title: In vitro activities of telavancin and six comparator agents against anaerobic bacterial isolates.
Journal: Antimicrobial agents and chemotherapy 20090901
Title: Microbiology of drugs for treating multiply drug-resistant Gram-positive bacteria.
Journal: The Journal of infection 20090901
Title: Activity of telavancin against Staphylococcus aureus strains with various vancomycin susceptibilities in an in vitro pharmacokinetic/pharmacodynamic model with simulated endocardial vegetations.
Journal: Antimicrobial agents and chemotherapy 20090701
Title: Lack of pharmacokinetic drug interactions following concomitant administration of telavancin with aztreonam or piperacillin/tazobactam in healthy participants.
Journal: Journal of clinical pharmacology 20090701
Title: In vitro activities of telavancin and vancomycin against biofilm-producing Staphylococcus aureus, S. epidermidis, and Enterococcus faecalis strains.
Journal: Antimicrobial agents and chemotherapy 20090701
Title: Antimicrobial development in the era of emerging resistance.
Journal: Mini reviews in medicinal chemistry 20090701
Title: Telavancin versus vancomycin for the treatment of complicated skin and skin-structure infections associated with surgical procedures.
Journal: American journal of surgery 20090601
Title: Comparative efficacies of telavancin and vancomycin in preventing device-associated colonization and infection by Staphylococcus aureus in rabbits.
Journal: Antimicrobial agents and chemotherapy 20090601
Title: Efficacy of telavancin against glycopeptide-intermediate Staphylococcus aureus in the neutropenic mouse bacteraemia model.
Journal: The Journal of antimicrobial chemotherapy 20090401
Title: Intracellular activity of antibiotics in a model of human THP-1 macrophages infected by a Staphylococcus aureus small-colony variant strain isolated from a cystic fibrosis patient: pharmacodynamic evaluation and comparison with isogenic normal-phenotype and revertant strains.
Journal: Antimicrobial agents and chemotherapy 20090401
Title: The role of telavancin in the treatment of MRSA infections in hospital.
Journal: Expert opinion on investigational drugs 20090401
Title: Postantibiotic effects of telavancin against 16 gram-positive organisms.
Journal: Antimicrobial agents and chemotherapy 20090301
Title: Telavancin: a new lipoglycopeptide for gram-positive infections.
Journal: Drugs of today (Barcelona, Spain : 1998) 20090301
Title: Efficacy of telavancin in the treatment of methicillin-resistant Staphylococcus aureus osteomyelitis: studies with a rabbit model.
Journal: The Journal of antimicrobial chemotherapy 20090201
Title: New antibiotics for healthcare-associated pneumonia.
Journal: Seminars in respiratory and critical care medicine 20090201
Title: Regulatory watch: Non-inferiority-trial discussions impact new drug applications.
Journal: Nature reviews. Drug discovery 20090101
Title: Telavancin.
Journal: Drugs 20090101
Title: Cost-effectiveness of telavancin versus vancomycin for treatment of complicated skin and skin structure infections.
Journal: Pharmacotherapy 20081201
Title: Telavancin and vancomycin pharmacodynamics with Staphylococcus aureus in an in vitro dynamic model.
Journal: The Journal of antimicrobial chemotherapy 20081101
Title: Non-susceptibility trends among staphylococci from bacteraemias in the UK and Ireland, 2001-06.
Journal: The Journal of antimicrobial chemotherapy 20081101
Title: A new lipoglycopeptide: telavancin.
Journal: Expert opinion on pharmacotherapy 20080801
Title: In vitro activity of telavancin against recent Gram-positive clinical isolates: results of the 2004-05 Prospective European Surveillance Initiative.
Journal: The Journal of antimicrobial chemotherapy 20080701
Title: Comparative surveillance study of telavancin activity against recently collected gram-positive clinical isolates from across the United States.
Journal: Antimicrobial agents and chemotherapy 20080701
Title: In vitro activity of telavancin against resistant gram-positive bacteria.
Journal: Antimicrobial agents and chemotherapy 20080701
Title: Cellular pharmacokinetics of telavancin, a novel lipoglycopeptide antibiotic, and analysis of lysosomal changes in cultured eukaryotic cells (J774 mouse macrophages and rat embryonic fibroblasts).
Journal: The Journal of antimicrobial chemotherapy 20080601
Title: Telavancin versus vancomycin for the treatment of complicated skin and skin-structure infections caused by gram-positive organisms.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20080601
Title: Telavancin: an antimicrobial with a multifunctional mechanism of action for the treatment of serious gram-positive infections.
Journal: Pharmacotherapy 20080401
Title: Dalbavancin and telavancin: novel lipoglycopeptides for the treatment of Gram-positive infections.
Journal: Expert review of anti-infective therapy 20080201
Title: Efficacy of telavancin in a murine model of pneumonia induced by methicillin-susceptible Staphylococcus aureus.
Journal: The Journal of antimicrobial chemotherapy 20080101
Title: In vitro evaluation of the activities of telavancin, cefazolin, and vancomycin against methicillin-susceptible and methicillin-resistant Staphylococcus aureus in peritoneal dialysate.
Journal: Antimicrobial agents and chemotherapy 20071201
Title: Update on prevalence and treatment of methicillin-resistant Staphylococcus aureus infections.
Journal: Expert review of anti-infective therapy 20071201
Title: Telavancin: a novel lipoglycopeptide antimicrobial agent.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20071115
Title: In vitro antimicrobial activity of telavancin against methicillin-resistant Staphylococcus aureus clinical isolates from Japan (2006).
Journal: The Journal of antibiotics 20071101
Title: In vitro activity of telavancin against gram-positive clinical isolates recently obtained in Europe.
Journal: Antimicrobial agents and chemotherapy 20070901
Title: Pharmacodynamic effects of telavancin against methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains in the presence of human albumin or serum and in an in vitro kinetic model.
Journal: Antimicrobial agents and chemotherapy 20070901
Title: Comparative activity of telavancin against isolates of community-associated methicillin-resistant Staphylococcus aureus.
Journal: The Journal of antimicrobial chemotherapy 20070801
Title: Efficacy of telavancin in the treatment of experimental endocarditis due to glycopeptide-intermediate Staphylococcus aureus.
Journal: Antimicrobial agents and chemotherapy 20070701
Title: Telavancin: a novel lipoglycopeptide for serious gram-positive infections.
Journal: Expert opinion on investigational drugs 20070301
Title: Evaluation of the extracellular and intracellular activities (human THP-1 macrophages) of telavancin versus vancomycin against methicillin-susceptible, methicillin-resistant, vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus.
Journal: The Journal of antimicrobial chemotherapy 20061201
Title: Efficacy of telavancin in a murine model of bacteraemia induced by methicillin-resistant Staphylococcus aureus.
Journal: The Journal of antimicrobial chemotherapy 20060801
Title: Comparative activity of the new lipoglycopeptide telavancin in the presence and absence of serum against 50 glycopeptide non-susceptible staphylococci and three vancomycin-resistant Staphylococcus aureus.
Journal: The Journal of antimicrobial chemotherapy 20060801
Title: Glycopeptides and glycodepsipeptides in clinical development: a comparative review of their antibacterial spectrum, pharmacokinetics and clinical efficacy.
Journal: Current opinion in investigational drugs (London, England : 2000) 20060801
Title: Antibacterial drug discovery and development--SRI's 11th Annual Summit.
Journal: IDrugs : the investigational drugs journal 20060601
Title: Telavancin versus standard therapy for treatment of complicated skin and skin structure infections caused by gram-positive bacteria: FAST 2 study.
Journal: Antimicrobial agents and chemotherapy 20060301
Title: Efficacy of telavancin against penicillin-resistant pneumococci and Staphylococcus aureus in a rabbit meningitis model and determination of kinetic parameters.
Journal: Antimicrobial agents and chemotherapy 20060201
Title: Telavancin: TD 6424, TD-6424.
Journal: Drugs in R&D 20060101
Title: New antibiotics for the treatment of severe staphylococcal infection in the critically ill patient.
Journal: Current opinion in critical care 20051001
Title: Efficacy of telavancin (TD-6424), a rapidly bactericidal lipoglycopeptide with multiple mechanisms of action, in a murine model of pneumonia induced by methicillin-resistant Staphylococcus aureus.
Journal: Antimicrobial agents and chemotherapy 20051001
Title: Telavancin: in vitro activity against staphylococci in a biofilm model.
Journal: The Journal of antimicrobial chemotherapy 20050801
Title: Efficacy of Telavancin in a rabbit model of aortic valve endocarditis due to methicillin-resistant Staphylococcus aureus or vancomycin-intermediate Staphylococcus aureus.
Journal: Antimicrobial agents and chemotherapy 20050801
Title: Telavancin versus standard therapy for treatment of complicated skin and soft-tissue infections due to gram-positive bacteria.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 20050601
Title: Telavancin, a multifunctional lipoglycopeptide, disrupts both cell wall synthesis and cell membrane integrity in methicillin-resistant Staphylococcus aureus.
Journal: Antimicrobial agents and chemotherapy 20050301
Title: Glycopeptides in clinical development: pharmacological profile and clinical perspectives.
Journal: Current opinion in pharmacology 20041001
Title: Pharmacodynamics of telavancin (TD-6424), a novel bactericidal agent, against gram-positive bacteria.
Journal: Antimicrobial agents and chemotherapy 20040801
Title: Effects of a new antibacterial, telavancin, on cardiac repolarization (QTc interval duration) in healthy subjects.
Journal: Journal of clinical pharmacology 20040701
Title: In vitro activities of the new semisynthetic glycopeptide telavancin (TD-6424), vancomycin, daptomycin, linezolid, and four comparator agents against anaerobic gram-positive species and Corynebacterium spp.
Journal: Antimicrobial agents and chemotherapy 20040601
Title: Comparative in vitro activity of telavancin (TD-6424), a rapidly bactericidal, concentration-dependent anti-infective with multiple mechanisms of action against Gram-positive bacteria.
Journal: The Journal of antimicrobial chemotherapy 20040501
Title: Hydrophobic vancomycin derivatives with improved ADME properties: discovery of telavancin (TD-6424).
Journal: The Journal of antibiotics 20040501
